The peripheral blood lymphocyte signatures forecast therapeutic efficacy in papillary thyroid cancer patients undergoing radioactive iodine therapy

Puntos clave

• Therapeutic efficacy is forecasted using peripheral blood lymphocyte signatures, indicating a promising predictor for patient outcomes.
• Key evidence shows a significant correlation between lymphocyte signatures and therapy response in papillary thyroid cancer patients.
• Observational analysis reveals the potential of lymphocyte signatures to guide radioactive iodine therapy effectiveness in treating papillary thyroid cancer.
• Findings support the use of lymphocyte signatures for personalized approaches in cancer therapy, calling for further validation across diverse populations.